Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Scientists say research into a vaccine for HIV is further along than it’s ever been. But Trump administration cuts to scientific research have set that effort back. Including a promising trial for an ...

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...

The incidence of skin diseases in people with HIV has declined significantly over the past decade, but some patient groups remain at a higher risk, particularly for cutaneous malignancies (CM), ...

HIV infection rates may be five times higher than thought in black urban women. March 9, 2012— -- The HIV rate among black women living in some U.S. cities is the same rate as that of some ...

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...

For most of its history, the US military has refused to recruit HIV-positive soldiers. The Trump administration appears to be ...